Bengaluru-based Biocon said that its Q4 profit stood at ₹198.6. The profit was hit by an exceptional item outgo of ₹80.4 crore on various heads, including the impact of the new labour code.

Novozymes Buys Enzyme Business of BIOCON Pharmaceuticals in India for $102 Million FRANKLINTON, N.C. -- Novozymes has today signed a definitive agreement under which it will acquire the enzyme ...

Biocon's fourth-quarter net profit saw a significant drop of 63 percent year-on-year. This decline was attributed to ...

Biocon shares jump 8% post Q4 results. Is the Street happy? Biocon's shares surged by 8% on Tuesday due to strong Q4 earnings growth. Net profit grew by 31% to INR 313 crore with ...

TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd.

Biocon Ltd on Friday issued a clarification through an exchange filing in response to media reports suggesting that the company was considering a merger of its unlisted subsidiary Biocon Biologics Ltd ...

On July 15, 2025, Biocon Biologics, a fully integrated global biosimilars company and a subsidiary of Biocon Ltd., announced that the FDA has approved KIRSTY (insulin aspart-xjhz injection), 100 units ...

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon ...

Biocon Ltd on Monday said its wholly owned subsidiary, Biocon Pharma Ltd, has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ...

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent ...

Biocon Ltd will acquire the remaining stake in Biocon Biologics from Serum Institute Life Sciences, Tata Capital Growth Fund II, Activ Pine LLP and Mylan Inc ...

Biocon Biologics, a unit of drugmaker Biocon Ltd, said late on Thursday it would offer a stake of about 15% to Serum Institute Life Sciences for access to 100 million doses of vaccines annually for 15 ...